Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Crohn's Disease, Obesity”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Not applicableUnknownNCT05230160
What this trial is testing

Can Intermittent Fasting Induce Weight Loss and Improve Gut Health as Compared to Standard Medical Care in Patients With Obesity/High BMI and Crohn's Disease.

Who this might be right for
Crohn Disease
University of Calgary 42
Not applicableStudy completedNCT03871634
What this trial is testing

Assessment of Nutritional Status of Patients With Crohn's Disease

Who this might be right for
Crohn's DiseaseMalnutritionOverweight and Obesity+2 more
Harokopio University 250
Not applicableEnded earlyNCT05579444
What this trial is testing

Systems Biology of Gastrointestinal and Related Diseases

Who this might be right for
Ulcerative ColitisCrohn DiseaseObesity+19 more
Viome 17
Not applicableUnknownNCT00488085
What this trial is testing

Crohn's Disease, Obesity and Disease Severity

Who this might be right for
Crohn's Disease, Obesity
Tel-Aviv Sourasky Medical Center 40
Not applicableUnknownNCT03840928
What this trial is testing

PatientSpot Formerly Known as ArthritisPower

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisFibromyalgia+61 more
Global Healthy Living Foundation 40,000
Not applicableLooking for participantsNCT04014413
What this trial is testing

Safety and Efficacy of Fecal Microbiota Transplantation

Who this might be right for
Crohn DiseaseUlcerative ColitisCeliac Disease+24 more
Chinese University of Hong Kong 450
Large-scale testing (Phase 3)Looking for participantsNCT06937099
What this trial is testing

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Who this might be right for
Crohn's DiseaseObesity or Overweight
Eli Lilly and Company 290